Endometrial Cancer Market Size By Application, By End Use, And Segment Forecasts 2022 - 2032

 

Endometrial Cancer Market Overview:

The global endometrial cancer market size is USD 24.08 Billion expecting a robust CAGR 4.2% and a strong market presence during the forecast period 2023-2032 in an all-inclusive study asserts Market Research Future (MRFR). Endometrial cancer is also known as uterine cancer and is the sixth most common cancer in women across the world. The daunting number speaks for itself and promotes the factors that ensure the market growth for endometrial cancer.

Market Dashboard:

The market is witnessing significant funding going into research and developments. For instance, Salk Institutes is getting a sizeable amount of fund from Padres Pedal the Cause. Others are mainly focusing on mergers and acquisitions. Royal Philips acquiring EPD Solutions can be taken exemplary. Boston Scientific has also acquired EMcision, Ltd. 

The prominent players involved in the market are

Pfizer Inc.,

General Electric Company,

Koninklijke Philips N.V.,

LUPIN, PHYTON,

Bayer AG,

Celgene Corporation,

Johnson & Johnson,

CooperSurgical Inc.,

LiNA Medical USA,

Conceptus Inc.,

Hologic Inc.,

Karl Storz GmbH & Co. Kg, and

Boston Scientific Corporation.

Drivers and Restraints:

Urbanization across the world is experiencing an express speed growth rate owing to which the population is undergoing remarkable lifestyle change. A sedentary lifestyle has become the norm for many, and growing obesity among women is resulting in the rising number of endometrial cancer. Lack of nutritional elements in consumed food and other diseases such as polycystic ovarian syndrome (PCOS) and the ovarian tumor can trigger endometrial cancer.

However, a few factors are currently acting as market irritants such as high diagnostic cost, expensive treatment, and side-effects associated with the procedure. Coupled with these factors, stringent government policies regarding the treatment can also create a bottleneck situation for the market.

Industry Trends:

According to the Journal of Clinical Oncology, researchers of John Hopkins Medicine have found a new way to treat uterine cancer by adding the drug trastuzumab to the chemotherapy regimen of the uterine cancer patients. The drug prolongs the tumor growth process and gives the physicians a better opportunity to cure the patients.     

A new finding by the researchers in Huntsman Cancer Institute (HCI) at the University of Utah reveals that in many uterine cancer tissues steroid and hormone receptors are acting simultaneously causing an escalation in the growth of the tumor.

PapSEEK is a type of liquid biopsy which is now enabling researchers to identify endometrial cancer at a very early stage. The screening procedure is still in its early stage, but it can surely benefit the doctors in diagnosing and treating their patients.

Segmentation:

The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user.

By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy. Endometrial biopsy is very common as the confirmatory test for uterine cancer.

Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category comprises open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy. External radiation and internal radiation (brachytherapy) are part of radiation technology. The hormonal therapy consists progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors. Chemotherapy can be further sub-segmented into paclitaxel, carboplatin, doxorubicin, and cisplatin and is also the most-used treatment method.

Based on the end-users the market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.

Regional Analysis:

Region-wise the global endometrial cancer market covers the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA).

The Americas are currently holding the largest market share and can continue to do so in the near future. The region is experiencing a growing number of endometrial patients who are spending much on diagnostic and treatment. The region has a well-structured healthcare system and extensive research units who are also contributing significantly to the regional market.

Europe is currently holding the second position in the market. Robust healthcare sector and advanced technologies are supporting the European market for uterine cancer treatment.

The APAC can also witness significant growth in the market owing to rising incidence of cervical cancer in countries such as India and China.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Smart Pills Market Outlook & Regional Analysis 2032

Market summery

Market Research Future (MRFR's) study on the global smart pills market share is projected to grow USD 2.01 billion by 2032 at a CAGR of 15.9% over the forecast period of 2023-2032.

Amidst cut-throat competition, reimbursement issues, and expiry of blockbuster patent drugs, there is immense pressure on the healthcare sector to innovate diagnosis solutions. This has provided fuel for the advancement and commercialization of the smart pill technology which has been there for decades.

Smart pills are aligned with smart pills such as greater flexibility, precise delivery, real-time measurements, and monitoring of GI tract, and controlled operation or performance have acted as factors which can be employed to great advantage in drug development. They have several important applications, especially in diagnosis.

With the surge in the occurrence of chronic diseases, especially gastrointestinal diseases, smart pills are increasingly emerging as an effective method of endoscopy. Lifestyle diseases such as gastroesophageal reflux disease (GERD), obesity, and gastric ulcers are on the rise due to rapid lifestyle changes and unhealthy eating habits. This has induced high demand for on-site diagnosis, and, in turn, drive the smart pills market research. Surging prevalence of colon cancer is a key factor which is motivating the growth of the smart pills market.

Smart pills have been a breakthrough in gastrointestinal tract diagnosis and are set to replace conventional methods of diagnosis such as colonoscopy and endoscopy. Capsule endoscopy has cropped up as an effective method to perform endoscopy which is non-invasive and causes very little discomfort. Increasing consumer preference for minimally invasive medical procedures is likely to induce greater demand within the smart pills market.

Application of smart pills in monitoring pH, temperature, pressure, and drug adherence are further expected to catapult the growth of the market. Considerable research in the field of smart pills purveyed by heavy investments is also favoring the growth of the market. Other factors fostering market growth include conducive reimbursement landscape and increasing geriatric population. On the other hand, the market growth is restricted by factors such as regulatory restrictions and high costs of smart pills.

Competitive Landscape

Global smart pills market players are CapsoVision, Inc., Proteus Digital Health, Inc., JINSHAN Science & Technology, MEDTRONIC, Check-Cap, BDD Limited, Olympus Corporation, PENTAX Medical, FUJIFILM Holdings Corporation, MEDISAFE, INTROMEDIC, and RF Co., Ltd. are the notable players in the global smart pills market.

Segmentation

The global smart pills market trends has been segmented based on application, target area, disease indication, and end user.

 

By application, the smart pills market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further segmented into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The patient monitoring segment has been further segmented into capsule pH monitoring and others.

By target area, the smart pills market has been segmented into esophagus, small intestine, large intestine, and stomach.

By disease indication, the smart pills market has been segmented into esophageal diseases, small bowel disases, colon diseases, and others.

By end user, the smart pills market has been segmented into hospitals, diagnostic center, and research institute.

Regional Analysis

By region, the smart pills market outlook has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

Conducive reimbursement scenario, the surging prevalence of chronic diseases, a nd fast uptake of advanced technology are the factors supporting the growth of the market in the region. The Americas account for the foremost share of the smart pills market.

Europe follows the Americas closely and accounts for the second most significant share of the smart pills market. Robust healthcare infrastructure, the high incidence rate of lifestyle-related diseases such as obesity, gastroesophageal reflux disease (GERD), and gastric ulcers have generated high demand for smart pills in the region. Moreover, European countries invest heavily in healthcare which acts as a plus for the growth of the market.

The APAC market is poised to perform relatively well and emerge as the fastest-growing market for smart pills. Percolation of advanced healthcare technologies in the region coupled with high healthcare expenditure in the developing countries of the region favors the growth of the market. Besides, increase in geriatric population and prevalence of various chronic diseases contribute to the growth of the market.

The minimum share of the smart pills market is held by MEA. Lack of knowledge, low healthcare penetration, and poor economic conditions, especially in the African region is hindering the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

E-Prescribing Systems Market Share, Insights and Forecast to 2030

 

Market Scenario

Market Research Future (MRFR), in its latest “E-Prescribing Systems Market” report, reveals various factors that are expected to write various factors that can control the growth course of the market. MRFR finding states that the global e-prescribe systems market share is projected to reach USD 1.76 billion by 2030 at 23.4% CAGR during the forecast period 2022-2030. The surge in need for providing better quality patient care is expected prompt the e-prescribing systems market size to increase. Practitioners and pharmacists are being highly benefitted by electronic prescription, which can promote the growth of the e-prescribing systems global market in the years to come. E-prescribing technology improves patient safety and enable easy access to patient medical history that can benefit in the correct choice for treatment regime. Thus, it can be concluded that the market of e-prescribing can thrive in coming years. In addition, increase in incentive programs launched by global governments to improve healthcare quality, cut healthcare expenses, and reduce prescription inaccuracies are causing surge in the adoption of e-prescription systems research.

Key Players                                                                                                        

Global e-prescribing systems market players are; Cerner Corporation, Aprima, Practice Fusion, Inc., eClinicalWorks, Surescripts, Allscripts, eMDs, Inc., Athena health Inc., iMedX Inc., and Henry Schein e-prescribe. Competitiveness among prominent players of the market can favor the global e-prescribing systems market to earn considerable turnover. MRFR report can assist key players to design strategies that can allow them to stay ahead of the progress curve.

Segmental Study

The e-prescribing systems market trends study can be segmented by mode of delivery, system type, end users, and component. Segmental insights of the e-prescription systems market can assist venture capitalist to discern areas for investment to yield substantial revenue. 

The system type-based segments of the market are integrated system and stand-alone system. The integrated system segment can win considerable profits for the e-prescription systems global market.

The mode of delivery-based segments of the market are web-based, cloud-based, and on-premise. Cloud-based e-prescription systems are likely to gain popularity in years to come, which can boost the market growth.

The component-based segments of the market are software, services, and hardware. Marketers are investing in the development of effective and smart e-prescription software.

The end user-based segments of the market are clinics, hospitals, and pharmacy. The immense benefits offered by e-prescriptions to its end-users can favor the market.

Regional Analysis

North America e-prescription systems market insights can secure the pole position globally. In the US, the surge in initiatives and funding by the government body can authorize the availability of potential scope of the e-prescribing systems market to surge. The availability of modern technical infrastructure can spur the expansion of the regional market.

Europe e-prescription systems market health to improve in the years to come. EU market can be benefitted by the rise in healthcare based projects and the availability of robust healthcare networks. The need to curb healthcare expenditure and the existence of medical infrastructure empowered with latest medical technologies are other driver of the EU e-prescribing systems market.

Asia Pacific e-prescribing systems market growth is likely to be expedited due to rise in the number of healthcare organizations, developing healthcare programmes, and launch of projects that can enhance patient safety and care. The growing inclination towards digitization to eliminate frauds and human errors, increase in healthcare expenditure, and the adoption for latest technologies can fuel the market growth.

The MEA e-prescribing systems market is expected for a slow growth through the study period. Lack of awareness about patient management software and limited access to modern treatment facilities can hinder the regional market growth.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Microdermabrasion Market Outlook Overview, Trends,Share and Forecast by 2032

Global Microdermabrasion Market – Synopsis

Acknowledging kind of the growth the market perceives currently; Market Research Future (MRFR) has recently published a study report giving out the complete market forecast up to 2023. In its analysis, MRFR asserts that the global Microdermabrasion market share projected to reach USD 1.04 Billion by 2032 with 8.50% CAGR during 2023-2032.

Microdermabrasion or microderm is a technique of exfoliation with the use of a machine to improve health and appearance of skin by sloughing off dead skin cells, allowing new cells to the surface. Considered as a non-invasive treatment Microdermabrasion is safe for individuals with all skin types and textures. However, Microdermabrasion treatment is generally used to remove various types of scars caused due to hyperpigmentation, acne & Trauma, Photo-Damage, and Stretch Marks, among others.

Scars, especially on the face affect a person’s appearance and hence personality, further making the person vulnerable to lose the self-confidence. With the rapid urbanization and increasing access to the improved healthcare, which is fuelled by the improving economic conditions, people are becoming conscious about their appearance. To refine their looks, they increasingly opt for Microdermabrasion. Augmenting uptake is the key factor for the growth of Microdermabrasion market research.

With the extensive research in the field, this treatment has become safer and effective to remove the scar. Manufacturers involved in the medical or these machines, strive to develop new and innovative products continually, which can provide advanced solutions to the scar removal, easing the processes further. Additionally, factors contributing the market growth include growing population & urbanization worldwide. Improving economic conditions, globally, are providing impetus to the market growth, increasing consumers’ purchasing power.

On the hand, factors such as the availability of alternative treatments such as chemical peel and laser skin resurfacing coupled with the increasing uptake of the laser resurfacing treatment are impeding the market growth.

Global Microdermabrasion Market – Competitive Landscape

The rapidly growing market for Microdermabrasion is fiercely competitive and fragmented with many well-established as well small & new entrants forming the competitive edge. Innovation, new technology launch and Brand reinforcement remain the popular trends for the key players in the market. The growth statistics of the Scar market presage the probable heights the market can reach further.

Microdermabrasion Market players including Procter & Gamble, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Silhouet-Tone, Altair Instruments, Advanced Microderm, Inc., New Shining Image LLC., Dermaglow, Lasertec Medical Service, and Delasco, lead the global Microdermabrasion market. Profiling them in its analysis MRFR finds out their strategies keeping them at the forefront of the market competition.

Global Microdermabrasion Market – Segments

MRFR has segmented the Microdermabrasion market trends into Four key dynamics: -

By Types                              : Comprising Diamond Microdermabrasion, and Crystal Microdermabrasion, among others.

By Products        : Microdermabrasion Machine (table top, hand-held, others.), Microdermabrasion Crystals (aluminium oxide crystals, sodium bicarbonate crystals, sodium chloride crystals, others.), Microdermabrasion Tips (diamond tips, bristle tips, others.), Microdermabrasion Creams and Scrubs, among other.

By Indications    : Hyperpigmentation, Acne & Trauma Scars, Photo-Damage, and Stretch Marks, among others.

By End Users                     : Dermatology Clinics, Hospitals and Home Care, among others.

By Regions                                         :  North America, Europe, APAC and Rest of the World.

Global Microdermabrasion Market – Geographical Analysis

Globally North America market dominates the Microdermabrasion market insights with the largest share owing to the presence of numerous facilities and availability of treatments for acne & trauma scar removal. Other factors such as increasing uptake of advanced technologies to address various dermal conditions like stretch marks, acne, and hyperpigmentation, among others, are substantiating the market growth. Owing to the rising demands for minimally invasive procedures, the North America market is expected to create a larger revenue pocket in the global market by 2023. The US, backed by the high expenditure on healthcare coupled with the increasing demand for Microdermabrasion treatments, accounts for the major contributor to the market growth.

Whereas Europe accounts for the second largest market for Microdermabrasion, globally, attributing to the recent advancements in the technology coupled with the augmenting uptake of the technology in the region.  Additionally, the presence of huge patient population and rising healthcare expenditure facilitates the regional market growth.

The Asia-Pacific market is emerging as the rapidly growing market for Microdermabrasion due to the increasing prevalence of acne and the development of related technologies mainly in the countries such as India, China, and Japan. Backed by the rising demand for minimally invasive procedures and increasing adoption of the technologies for Scar removal, APAC market is expected to register a phenomenal CAGR during the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Bioadhesive Market Share, Trends, Industry Analysis Report Forecast 2030

Global Bioadhesive Market: Overview

The Global Bioadhesive Market share is expected is expected to grow USD 9.26 billion with a CAGR of 6.80% during the forecast period 2023-2030. According to a recent study report published by the Market Research Future, the global bio adhesive market research is expected to gain eminence over the forecast period. The market is forecast to demonstrate a solid growth by 2030 with a remarkable CAGR during the expected period from 2022 – 2030.

Over the last decade, bioadhesives have been considered a potential drug delivery system for oral administration that includes nasal spray, ear drops, eye drops, and ointment hydrogel among others. Bio adhesives are polymers that act as adhesives that contain protein and carbohydrates as major constituents. They are either natural or synthetic polymers. Naturals bio adhesive involve the use of microorganisms like bacteria, fungi, algae, etc. Synthetic polymers are made from biological monomers like sugars. Bio adhesives have number of advantages encouraging their use in healthcare involves their extensive application in drug delivery and tissue repair. They are primarily employed in end user industries such as healthcare, biotechnology, research institutes, packaging industries, etc. The demand of bio adhesives is increasing sue to increase in end users industries.

Global Bioadhesive Market   - Competitive Analysis

The bioadhesive industry has turned into a critical and element power in the global healthcare industry. Through extensive research, it is found out that there has been an extensive utilization in packaging and durability in the market. As there are plenty of large and small market players available. Global Bioadhesive Market Players operating in this market are

Bioadhesive

Alliance Inc.,

Camurus,

Henkel Corporation,

Ashland Inc.,

3M Company,

Adhesives Research,

Yparex B.V.,

EcoSynthetix Inc.,

Adhbio and

others.

Global Bioadhesive Market   - Regional Analysis

Global bio adhesive market outlook is segmented into four key regions: Americas, Europe, Asia-Pacific and Middle East and Africa. Europe is the largest market for bio adhesives in terms of production. Majority of bio adhesive manufacturers in Europe export their products to North America and Asia-Pacific. Increase in research and development activities in bio adhesives favor the growth of this market in Europe. Moreover, biotechnology and research laboratories use bio adhesives on a large scale in this region. America is the second largest market for bio adhesives due to increase in demand of eco-friendly bio adhesive for tissue repair and drug delivery that has favoured the growth of this market in America. Growing emphasis on personal care also increase the demand of bio adhesives in America. Asia-Pacific market is expected to show steady growth in the bio adhesive market trends during the forecasted period. Japan and India import bio adhesives from European companies which is signifies that there is an increasing demand for bio adhesives for Asia-Pacific for bio adhesive. Middle East and Africa show slow growth in this market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Magnetic Resonance Imaging Systems Market Size : A Global Analysis of the Market Trends

 

Market Scope

The Magnetic Resonance Imaging Systems Market Insights is expected to reach USD 5,100 Million by 2030 at 7.30% CAGR during the forecast period 2022-2030.

We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.

Top Market Firms

Hitachi,

Siemens AG,

Canon Medical Systems,

Xingaoyi,

Philips,

Toshiba Corporation,

Aurora Imaging Technologies, Inc.,

GE Healthcare,

Toshiba Corporation,

are among some of the top Magnetic Resonance Imaging Systems Market Players listed in the MRFR study.

Market Segmentation

The Global Magnetic Resonance Imaging Systems Market Report has been considered for type, field strength, disease application and end user.

Taking into account type, the market primarily caters to closed MRI, open MRI, wide-bore MRI and standard bore MRI.

Depending on field strength, the key segments can be very-high-field MRI systems, 1.5t MRI systems, high-field MRI systems, low-to-mid-field MRI systems, 3t MRI systems, and others.

Considering the disease application, the segments include cardiovascular MRI, brain and neurological MRI, spine and musculoskeletal MRI, breast MRI, pelvic and abdominal MRI, and others

With respect to end user, the market has been split into hospitals and clinics, diagnostic imaging centers, pharmaceutical &biotechnology companies and research laboratories.

Top Drivers and Main Barriers

Cutting edge technologies and intensive Magnetic Resonance Imaging Systems Market Research have resulted in the introduction of multiple advanced magnetic resonance imaging equipment that helps patients have longer and healthier lives. Magnetic resonance imaging technology is a diagnostic system that obtains information from the body’s interior and is extensively used in additional technical applications. A magnetic resonance imaging procedure helps create a 3D image of either the object or the patient that is being studied, without causing any hurt and without the use of ionizing radiation. With the substantial growth in the number of disorders related to neurology, spine, cardiovascular, orthopedic, neck and head, prostate and abdominal, the demand for advanced magnetic resonance imaging equipment has surged exponentially worldwide.

Magnetic Resonance Imaging Systems Market Overview and Analysis By Type (Open MRI and Close MRI), Field Strength (High-Field MRI Systems), Disease Application (Brain and Neurological MRI), and by End-Users (Hospitals & Clinics) - Forecast Till 2030

Regional Outlook

Europe, Americas, MEA or Middle East and Africa and Asia Pacific or APAC are the top Magnetic Resonance Imaging Systems Market.

America remains the market leader, observing the highest demand and use of magnetic resonance imaging (MRI) systems. The key reasons responsible for the region’s lead in the global market could be the heavy burden of neurological, ophthalmic and cardiovascular disorders, especially among the geriatric populace. Rigorous government efforts as well as spending on researches pertaining to medical devices along with the escalating demand for correct diagnosis also benefit the regional market. Substantial awareness level regarding the toxic effects of using radiation imaging, and the huge numbers of pharmaceutical firms present in the region also induces significant market growth.

APAC is touted to witness the fastest growth, as it demonstrates maximum growth possibilities. The massive patient pool, willingness to adopt latest healthcare technologies and government initiatives to improve the healthcare infrastructure are some of the top growth boosters. The improving insurance schemes and policies for patients, cheap costs of clinical trials and the intensive researches conducted by the prominent vendors in the region also enhance the market size. The rising number of players setting up their manufacturing units in Singapore, Japan, China, Australia and Korea also boosts the APAC market’s growth potential.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Biologic Therapy Market Size, Insights, Application & Growth Drivers

 

Global Biologic Therapy Market to Grow Healthily over 2023

Biologic therapy is gaining traction. According to a report published by Market Research Future (MRFR), the global biologic therapy market size is set to reach USD 288.03 billion by 2030 at a CAGR 8.20% over the forecast years 2023-2030. Biologic therapy is viewed as an innovative treatment module based on products sourced from living organisms.

Biologic therapy is used to stimulate or suppress the immune system for treatment purposes. The therapy finds application in treatment of diseases such as infection, cancer and several other diseases. Advances in the field of biologic therapeutic is boosting the application scope of biologic therapy. Rising demand for biological and targeted drug therapies is making a positive impact on the global biological therapy market. The R&D pipeline for biologic therapy is expected to grow in the future as pharmaceutical companies realise the vast market opportunities. 

Global Biologic Therapy Market: Competition Analysis

Global biologic therapy market players include

          ·           Bristol-Myers Squibb,

          ·           Amgen Inc.,

          ·           Eli Lilly,

          ·           Seattle Genetics, Inc.,

          ·           GlaxoSmithKline Plc.,

          ·           Novartis International AG,

          ·           Celgene Corporation and

          ·           Spectrum Pharmaceuticals, Inc.

Global Biologic Therapy Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on therapy, product type, end-user and application. Based on therapy, the market has been segmented into vaccines therapy, cell therapy, protein therapy and others. Based on product type, the market has been segmented into services, instruments and kit and reagents. Based on end-user, the market has been segmented into hospitals and clinic, research centers and speciality centers. Based on application, the market has been segmented into blood and blood-related products testing, tissue and tissue-related products testing, vaccine and therapeutics development, stem cell research and cellular and gene therapy.

Global Biologic Therapy Market: Regional Analysis

On the basis of region, the biologic therapy market insights has been segmented into North America, Europe, the Middle East & Africa (MEA), Latin America and Asia Pacific (APAC). North America represents an important market for biologic therapy. Rising geriatric population, growing cancer prevalence in countries such as the U.S. and Canada are some of the factors supporting the market growth in the region. Data released by United States Census Bureau reveals that the total count of Americans aged 65 and above surpassed 49.2 Mn in 2016. Advanced countries in North America have robust health coverage policies along with a quicker access to latest biologic therapeutics. Many market players operating in North America are focusing on patient-centric products. In addition, companies are focusing on delivering customized therapeutics. High healthcare spending in the region is also influencing the market growth. The Center for Disease Control and Prevention reported that healthcare expenditure in the U.S reach to 3.2 trillion in 2015.

Europe in hold the second spot in the global biologic therapy market in terms of revenue. The market in Europe is expected to exhibit a healthy growth over the next couple of years. The healthcare sector remains focused on innovation and continue to excel in delivering quality care. In addition, presence of an advanced healthcare system is reflecting favourably on the market in the region. Many of the advanced countries in Europe have large pool of geriatric population. Data released by Eurostat revealed that more that 19% of the over population in Europe is aged 65 and above.

Asia Pacific is emerging as a highly attractive market for biologic therapy. It is projected that the market in APAC will demonstrate the fastest growth during the forecast period. Increased occurrence of lifestyle diseases is driving the demand for biologic therapy. Rising healthcare expenditure, increased awareness level and improving healthcare infrastructure are some of the key factors influencing the market in APAC.

The market in MEA is expected to witness a relatively slower growth during the forecast period. This is mainly owing low penetration and limited access. However, increased efforts towards improving healthcare standard in GCC countries is likely to create market opportunities.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America